|
|
|
|
|
|
|
NOTE 1 — ORGANIZATION AND SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
Organization and Business
Scio Diamond Technology Corporation (referred to herein as the “Company”, “we”, “us” or “our”) was incorporated under the laws of the State of Nevada as Krossbow Holding Corp. on September 17, 2009. The original business plan of the Company was focused on offsetting carbon dioxide emissions through the creation and protection of forest-based carbon “sinks.” The Company has since abandoned its original business plan and restructured its business to focus on man-made diamond technology development and commercialization.
Prior to October 1, 2012, the Company was a development stage company. Developmental activities have ceased and planned principal operations have commenced.
On September 16, 2013, the Company entered into a series of agreements with SAAMABA, LLC and S21 Research Holdings (the “Grace Rich Agreements”) to form a joint venture with operations in the People’s Republic of China to deploy 100 Scio designed diamond growing machines. The agreements allow for the expansion of the joint venture to 400 or more machines. Under the Grace Rich Agreements, the Company has agreed to license its proprietary technology for the manufacture of diamond gemstones of agreed upon specifications. In exchange for the license, the Company will receive licensing and development revenue and a 30% ownership position in the joint venture. In addition to the licensed technology, the Grace Rich Agreements include obligations for the Company to provide and be compensated for technology consulting services to the joint venture to support the start-up of operations.
Going Concern
The Company has generated very little revenue to date and consequently its operations are subject to all risks inherent in the establishment and commercial launch of a new business enterprise.
These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management has responded to these circumstances by taking the following actions:
· On-going solicitation of investment in the Company in the form of private placements of common shares, secured and unsecured debt to accredited investors;
· Focused efforts on new business development opportunities to generate incremental revenues and diversify our customer base; and
· Began exploring strategic joint ventures, technology licensing agreements and dedicated contract manufacturing to expand company revenue and cash flow including our recently agreed to joint venture in China.
In the opinion of management, these actions should be sufficient to provide the Company with the liquidity it needs to meet its obligations and continue as a going concern. There can be no assurance, however, that the Company will successfully implement these plans. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Accounting Basis
The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations.
In the opinion of management, the accompanying unaudited financial statements contain all adjustments (consisting only of normal recurring accruals) necessary to present fairly the Company’s financial position as of September 30, 2013 and March 31, 2013 and the results of operations and cash flows for the three and six month interim periods ended September 30, 2013 and 2012. All interim amounts have not been audited, and the results of operations for the interim periods herein are not necessarily indicative of the results of operations to be expected for future periods or the year. The balance sheet at March 31, 2013 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements. These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Form 10-K Annual Report of the Company for the year ended March 31, 2013.
Basic and Diluted Net Loss per Share
Net loss per share is presented under two formats: basic net loss per common share, which is computed using the weighted
average number of common shares outstanding during the period, and diluted net loss per common share, which is computed using the weighted average number of common shares outstanding, and the weighted average dilutive potential common shares outstanding, computed using the treasury stock method. Currently, for all periods presented, diluted net loss per share is the same as basic net loss per share as the inclusion of weighted average shares of common stock issuable upon the exercise of options and warrants would be anti-dilutive.
The following table summarizes the number of securities outstanding at each of the periods presented, which were not included in the calculation of diluted net loss per share as their inclusion would be anti-dilutive:
|
|
September 30, |
| ||
|
|
2013 |
|
2012 |
|
Common stock options and warrants |
|
9,778,045 |
|
10,791,264 |
|
Allowance for Doubtful Accounts
An allowance for uncollectible accounts receivable is maintained for estimated losses from customers’ failure to make payment on accounts receivable due to the Company. Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of accounts receivable and (3) specific information obtained by the Company on the financial condition and the current credit worthiness of its customers. The Company has determined that an allowance was not necessary at September 30, 2013 or March 31, 2013.
Inventories
Inventories are stated at the lower of average cost or market. The carrying value of inventory is reviewed and adjusted based upon slow moving and obsolete items. Inventory costs include material, labor, and manufacturing overhead and are determined by the “first-in, first-out” (“FIFO”) method. The components of inventories are as follows:
|
|
September 30, |
|
March 31, |
| ||
Raw materials and supplies |
|
$ |
132,462 |
|
$ |
64,255 |
|
Work in process |
|
22,486 |
|
— |
| ||
Finished goods |
|
331,911 |
|
474,693 |
| ||
|
|
486,859 |
|
538,948 |
| ||
Inventory reserves |
|
(55,508 |
) |
— |
| ||
|
|
$ |
431,351 |
|
$ |
538,948 |
|
During the six months ended September 30, 2013, we established a lower cost of market reserve of $55,508 due to expected selling prices being lower than cost. The estimation of the total write-down involves management judgments and assumptions including assumptions regarding future selling price forecasts, the estimated costs to complete, disposal costs and an expected profit margin.
Property, Plant and Equipment
Depreciation of property, plant and equipment is on a straight line basis beginning at the time it is placed in service, based on the following estimated useful lives:
|
|
Years |
|
Machinery and equipment |
|
3–15 |
|
Furniture and fixtures |
|
3–10 |
|
Engineering equipment |
|
5–12 |
|
Leasehold improvements are depreciated over the lesser of the remaining term of the lease or the life of the asset (generally three to seven years).
Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred. Manufacturing equipment was placed into service beginning July 1, 2012.
Intangible Assets
Intangible assets, such as acquired in-process research and development costs, are considered to have an indefinite useful life until such time as they are put into service at which time they will be amortized on a straight-line basis over the shorter of their economic or legal useful life. Management evaluates indefinite life intangible assets for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired. The ongoing evaluation for impairment of its indefinite life intangible assets requires significant management estimates and judgment.
Management reviews definite life intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There were no impairment charges during the six months ended September 30, 2013 or 2012.
Fair Value Measurement
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy prescribed by the accounting literature contains three levels as follows:
Level 1— Quoted prices in active markets for identical assets or liabilities.
Level 2— Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3— Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.
In addition, GAAP requires the Company to disclose the fair value for financial assets on both a recurring and non-recurring basis. On August 31, 2011, the Company issued to certain current and former stockholders of Apollo Diamond Inc. (“ADI”) that were at that time accredited investors subscription rights valued at $11,040,000 for the purchase of ADI assets disclosed in Note 2 measured at fair value on a nonrecurring basis. The fair value of the ADI subscription rights was determined based on an appraisal which used the Black-Scholes model whose assumptions were considered by management to be a Level 3 input. During September 2012, the Company issued to certain current and former stockholders of Apollo Diamond Gemstone Corporation (“ADGC”) that were at the time accredited investors subscription rights valued at $770,000 for the purchase of ADGC assets disclosed in Note 2 measured at fair value on a nonrecurring basis. The fair value of the ADGC subscription rights was determined using the Black-Scholes model whose assumptions were considered by management to be a Level 3 input.
As of September 30, 2013, the Company had 425,545 warrants outstanding with exercise prices of $0.70 per share. The warrants expire in 2016 and 2017. The warrants were issued by the Company as compensation for consulting work, placement agent services, and in exchange for cash discounts on facility rent, and are valued at $0.52 per warrant using the Black-Scholes model. In addition, the Company has 200,000 warrants outstanding with exercise prices of $1.60 per share. These warrants expire in 2018 and were issued by the Company as compensation to a Board member and an unaffiliated third party for efforts related to the Company’s largest customer and were valued at $0.57 per warrant using the Black-Scholes model.
The carrying value of cash and cash equivalents including restricted cash, accounts receivable, other assets and trade accounts payable approximates fair value due to the short-term nature of these instruments.
Revenue Recognition
We recognize revenue when persuasive evidence of an arrangement exists, delivery of products has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. For our Company, this generally means that we recognize revenue when we or our fabrication vendor has shipped finished product to the customer. Our sales terms do not allow for a right of return except for matters related to any manufacturing defects on our part. The Company also maintains a provision for estimating returns and allowances based upon historical experience.
Recent Accounting Pronouncements
There are currently no accounting standards that have been issued but not yet adopted by the Company that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption.
|
NOTE 2 — ASSET PURCHASES
On June 5, 2012, the Company acquired certain of the assets of ADGC (the “ADGC Asset Purchase”), consisting primarily of lab-created diamond gemstone-related know-how, inventory, and various intellectual property, in exchange for $100,000 in cash and the right for certain current and former stockholders of ADGC qualifying as accredited investors to acquire up to approximately 1 million shares of common stock of the Company for $0.01 per share (the “ADGC Offering”). The Company paid the $100,000 cash portion of the ADGC Asset Purchase during the month of December 2012. The ADGC Offering began in June 2012 and was completed in March 2013. The Company obtained a third-party valuation to support the fair value of the assets acquired. This valuation determined a value of $770,000 for the subscription rights. The amounts allocated to the ADGC assets acquired are based upon the results of that valuation appraisal and the following table reflects our final purchase price allocation of the assets:
Inventory |
|
$ |
269,000 |
|
In-process research and development |
|
601,000 |
| |
Total |
|
$ |
870,000 |
|
The ADGC Offering was completed in March 2013 and resulted in the issuance of an aggregate of 988,380 shares of the Company’s common stock.
|
NOTE 3 — INTANGIBLE ASSETS
During the six months ended September 30, 2013, the Company evaluated its patent portfolio and allocated $601,000 of the previously acquired in-process research and development from the ADGC Asset Purchase to specific patents related to the gemstone market that are being used by the Company for its commercial operations. These patents were considered placed in service by the Company during the quarter ended June 30, 2013 and the values assigned are being amortized on a straight-line basis over the remaining effective lives of the patents.
Intangible assets consist of the following:
|
|
|
|
September 30, |
|
March 31, |
| ||
|
|
Life |
|
2013 |
|
2013 |
| ||
Patents, gross |
|
6.75 – 19.46 |
|
$ |
8,135,063 |
|
$ |
7,534,063 |
|
In-process research and development |
|
Indefinite |
|
2,250,435 |
|
2,851,435 |
| ||
|
|
|
|
10,385,498 |
|
10,385,498 |
| ||
Accumulated amortization |
|
|
|
757,353 |
|
369,847 |
| ||
Net intangible assets |
|
|
|
$ |
9,628,145 |
|
$ |
10,015,651 |
|
Total amortization expense for the three and six months ending September 30, 2013 was $193,753 and $387,506, respectively. There was no amortization expense for the three and six months ended September 30, 2012.
Total annual amortization expense of finite lived intangible assets is estimated to be as follows:
Fiscal Year Ending |
|
|
| |
Six months ending March 31, 2014 |
|
$ |
387,506 |
|
March 31, 2015 |
|
775,011 |
| |
March 31, 2016 |
|
775,011 |
| |
March 31, 2017 |
|
775,011 |
| |
March 31, 2018 |
|
775,011 |
| |
Thereafter |
|
$ |
3,890,160 |
|
|
NOTE 4 — NOTES PAYABLE
On June 21, 2013, the Company entered into a loan agreement (the “Original Loan Agreement”) with Platinum Capital Partners, LP (“Platinum”) providing for a $1 million secured revolving line of credit that the Company may draw on to fund working capital and other corporate purposes. At September 30, 2013, the Company had utilized a portion of these funds to fund its ongoing operations. Borrowings under the loan agreement accrue interest at the rate of 18% per annum, payable monthly on or before the last calendar day of each month, and a service charge of 3% applies to late payments. The Original Loan Agreement also provides for payment of an accommodation fee of up to 10% of the commitment amount as provided in the loan agreement, and payment of a monthly collateral monitoring fee of $2,000 per month for the first six months and $1,000 per month for the last six months of the term of the loan agreement. The credit facility matures on June 20, 2014. The Original Loan Agreement contains a number of restrictions on the Company’s business, including restrictions on its ability to merge, sell assets, create or incur liens on assets, make distributions to its shareholders and sell, purchase or lease real or personal property or other assets or equipment. The Original Loan Agreement also contains affirmative covenants and events of default. The Company may prepay borrowings without premium or penalty upon notice to Platinum as provided in the Original Loan Agreement. Under a security agreement entered into in connection with the loan agreement, the Company granted Platinum a first priority security interest in the Company’s inventory, equipment, accounts and other rights to payments and intangibles as security for the loan.
The Company had an outstanding balance on this note of $974,105 at September 30, 2013 and was compliant with all financial debt convents. The remaining $25,895 of availability on this note is reserved to make certain interest payments on the note. On October 11, 2013, the Company and Platinum amended the Original Loan Agreement to provide for an additional $500,000 of borrowing capacity as described in Note 9: Subsequent Events.
|
NOTE 5 — CAPITAL STOCK
The authorized capital of the Company is 75,000,000 common shares with a par value of $ 0.001 per share.
During the six months ending September 30, 2012, Company issued 2,538,750 units, each consisting of one share of common stock and one warrant for the purchase of a share of common stock at a strike price of $1.60, at a unit price of $0.80 for total net cash proceeds of $1,998,920.
On June 4, 2013 the Company engaged Arque Capital LTD., Maxwell Simon, Inc., and Stonegate Securities, Inc. to provide consulting services in connection with future capital raising activities. The Company issued 165,000, 162,500 and 200,000 shares of its common stock, respectively to each of Arque Capital LTD., Maxwell Simon, Inc. and Stonegate Securities Inc., respectively as partial compensation for these engagements. The Company recognized $200,450 in expense related to these share issuances.
On September 25, 2013 the Company issued 1,000,000 shares of its common stock to our attorneys Schwegman, Lundberg & Woessner in exchange for $153,272 of past legal services.
The Company had 50,264,312 shares of common stock issued and outstanding as of September 30, 2013 of which 1,000,000 were held in treasury.
The Company had 5,516,795 warrants outstanding with a weighted average exercise price of $1.53 per share as of September 30, 2013. No warrants were issued in the six months ended September 30, 2013.
|
NOTE 6 — SHARE-BASED COMPENSATION
The Company currently has one equity-based compensation plan under which stock-based compensation awards can be granted to directors, officers, employees and consultants providing bona fide services to or for the Company. The Company’s 2012 Share Incentive Plan was adopted on May 7, 2012 (the “2012 Share Incentive Plan” or “Plan”) and allows the Company to issue up to 5,000,000 share of its common stock pursuant to awards granted under the 2012 Share Incentive Plan. The Plan permits the granting of stock options, stock appreciation rights, restricted or unrestricted stock awards, phantom stock, performance awards, other stock-based awards, or any combination of the foregoing. The only awards that have been issued under the Plan are stock options. Because the Plan has not been approved by our shareholders, all such stock option awards are non-qualified stock options. As of September 30, 2013, 813,750 shares remained available for issuance under the Plan.
On September 25, 2013, the Company granted nine non-executive employees options to purchase a total of 500,000 shares of the Company’s stock. These options vest based on the Company meeting various operating metric and cash flow targets. The exercise price of $0.33 per share is equal to the closing price of a share of the Company’s common stock on the date of grant. Using the Black-Scholes option pricing model, management has estimated the options issued on September 25, 2013 had a value of $0.21 per option on the date of the grant. None of these options were vested upon issuance and the Company recognized no compensation costs for these options as of September 30, 2013.
The assumptions used and the calculated fair value of the September 30, 2013 options are as follows:
Expected dividend yield |
|
0.00 |
% | |
Risk-free interest rate |
|
.66 |
% | |
Expected life in years |
|
3.00 |
| |
Expected volatility |
|
102.3 |
% | |
Weighted average calculated value of options granted |
|
$ |
0.21 |
|
The following sets forth the options to purchase shares of the Company’s stock issued and outstanding as of September 30, 2013:
Options |
|
Shares |
|
Weighted- |
|
Weighted-Average |
| |
Options Outstanding March 31, 2013 |
|
4,092,500 |
|
$ |
0.87 |
|
2.54 |
|
Granted |
|
500,000 |
|
0.33 |
|
2.99 |
| |
Exercised |
|
— |
|
— |
|
— |
| |
Expired/cancelled |
|
(406,250 |
) |
0.88 |
|
— |
| |
Options Outstanding September 30, 2013 |
|
4,186,250 |
|
$ |
0.79 |
|
1.87 |
|
Exercisable at September 30, 2013 |
|
1,703,833 |
|
$ |
0.82 |
|
2.01 |
|
Prior to December 2012, the Company’s practice was to issue options with exercise prices of $0.70 or $0.80 per share which were the prices of recent equity capital investment. However, in December 2012, the Company decided to change the exercise price policy by utilizing the stock market closing price on the day that the options were granted by our Board of Directors. All subsequent exercise prices have been determined in this manner.
The intrinsic value of options outstanding at September 30, 2013 and March 31, 2013 was $0 and $299,900, respectively. The intrinsic value of options exercisable at September 30, 2013 and March 31, 2013 was $0 and $176,109, respectively.
A summary of the status of non-vested shares as of March 31, 2013 and changes during the six months ended September 30, 2013 is presented below.
|
|
|
|
Weighted Average |
| |
|
|
|
|
Grant-Date |
| |
Non-vested Shares |
|
Shares |
|
Fair Value |
| |
Non-vested at March 31, 2013 |
|
2,466,278 |
|
$ |
0.65 |
|
Granted |
|
500,000 |
|
0.21 |
| |
Vested |
|
(343,750 |
) |
0.73 |
| |
Expired/cancelled: non-vested |
|
(200,000 |
) |
0.43 |
| |
Non-vested at September 30, 2013 |
|
2,482,417 |
|
$ |
0.57 |
|
The Company estimates the fair value of options granted on the grant date utilizing the Black-Scholes Option model. For the six months ended September 30, 2013 and 2012, the Company recognized $133,409 and $1,267,749, respectively, as compensation cost for options issued, and recorded related deferred tax asset of $0 for all periods.
At September 30, 2013, unrecognized compensation cost related to non-vested awards was $1,134,425. This cost is expected to be recognized over a weighted average period of 2.75 years. The total fair value of shares vested during the six months ended September 30, 2013 and 2012 was $133,409 and $997,165, respectively.
|
NOTE 7 — RELATED PARTIES
The Company incurred expenses of $19,658 and $64,266 for professional and consulting services provided by AdamsMonahan, LLP, a firm in which our board member, Edward S. Adams and former board member Michael R. Monahan, are partners, for the six months ended September 30, 2013 and 2012, respectively. The Company and AdamsMonahan, LLP amicably terminated their professional relationship on June 30, 2013.
On June 5, 2012, the Company acquired substantially all of the assets of ADGC, consisting primarily of cultured diamond gemstone-related know-how, inventory, and various intellectual property, in exchange for $100,000 in cash and the opportunity for certain current and former stockholders of ADGC that are accredited investors to acquire up to approximately 1 million shares of common stock of the Company for $0.01 per share. These rights were valued at $770,000 based on an external appraisal. Mr. Adams and Mr. Monahan served in various capacities with ADGC through early 2011.
On March 6, 2013, the Board of Directors retained Mr. Michael Monahan, who at the time was a member of the Company’s Board, and Mr. Theo Strous, a current director, to provide consulting services for the Company at a total cost of $11,000 and $4,000 respectively, per month. These consulting service agreements with both Messrs. Monahan and Strous were terminated effective June 30, 2013. The Company recognized $45,000 in consulting expense for these services during the six months ended September 30, 2013.
On May 14, 2013 the Board of Directors created a special committee consisting of Mr. Theo Strous to evaluate a report to the Board of Directors by former counsel to the Company and certain actions of a former member of the Board of Directors and former Company officers. The report was completed at the end of June 2013. The Board of Directors approved the payment of $25,000 to Mr. Strous as compensation for his service on the special committee.
On March 25, 2013, the Board of Directors agreed to indemnify Messrs. Adams and Monahan for expenses incurred and common stock they provided to settle litigation in May 2012. On May 21, 2013, the Company deemed issued the 1,000,000 shares previously allocated for indemnification of Messrs. Adams and Monahan and on July 2, 2013, the Company entered into an agreement with Mr. Adams to pay out remaining indemnification related liabilities of $117,305.93 at $7,500 per month through October 2014.
|
NOTE 8 — LITIGATION
On July 26, 2013, Bernard M. McPheely, Trustee for the Bernard M. McPheely Revocable Trust Dated May 25, 2012, Thomas P. Hartness, Trustee for the Thomas P. Hartness Revocable Trust Dated July 31, 2010, Brian McPheely and Robert Daisley (collectively, “plaintiffs”), derivatively and on behalf of the Company, filed a complaint in the Court of Common Pleas of the State of South Carolina, County of Greenville against Edward S. Adams (our Chairman), Michael R. Monahan (a former member of the Company’s Board of Directors), Robert Linares (a current member of the Board), Theodorus Strous (a current member of the Board) and the law firm of Adams Monahan, LLP (collectively, “defendants”), and the Company, as a nominal defendant (the “Scio Derivative Complaint”). Bernard M. McPheely is a former member of the Company’s Board of Directors.
The Scio Derivative Complaint alleges (i) against defendants, breach of fiduciary duty, corporate waste and unjust enrichment; (ii) against Messrs. Strous and Linares and Adams Monahan LLP, aiding and abetting a breach of fiduciary duty; (iii) against Messrs. Adams and Monahan, civil conspiracy; (iv) against Messrs. Adams, Monahan and Linares, breach of fiduciary duty — controlling shareholder; and (v) against Mr. Strous and Adams Monahan LLP, aiding and abetting a breach of controlling shareholder duty. The allegations relate to, among other things, certain actions allegedly taken by defendants in connection with: the acquisition by the Company of certain assets of Apollo Diamond, Inc. (“ADI”) (the “ADI Asset Purchase”); the ADGC Asset Purchase discussed in Note 2 above; the Company’s agreement to provide certain current and former stockholders of ADI and ADGC the opportunity to acquire up to approximately 16 million and 1 million shares, respectively, of common stock of the Company for $0.01 per share (collectively, the “ADI/ADGC Offering”); the provision of legal services by Adams Monahan LLP to the Company; certain equity issuances by the Company following the ADI/ADGC Offering; certain bonuses and other payments paid to members of the Board of Directors; and certain indemnification obligations undertaken by the Company in favor of Messrs. Adams and Monahan.
Plaintiffs are seeking direct and consequential damages sustained by the Company in an amount to be established through proof at trial, plus pre-judgment and post-judgment interest; appropriate equitable relief to remedy the alleged breaches of fiduciary duties; reasonable attorney’s fees and costs for the Company incurred in prosecuting the action; and other relief as deemed by the court to be just and proper. The defendants believe the Scio Derivative Complaint to be without merit and are vigorously defending it.
|
NOTE 9: SUBSEQUENT EVENTS
On October 1, 2013, the Company’s Board of Directors approved the issuance of 68,750 stock options to each of Messrs. Adams, Linares, and Strous for their services throughout calendar 2013. The grant is in accordance with the Company’s director compensation program that provides 6,250 options to each director for each Board meeting held. All 206,250 options issued have an exercise price of $0.42 that reflects the Company’s closing stock price on the date of grant.
On October 11, 2013, the Company entered into a First Amendment to Loan Agreement (the “First Amendment”), dated October 11, 2013, with Platinum, which amends Original Loan Agreement, as amended by the First Amendment, the “Amended Loan Agreement”) to provide for an additional $500,000 of borrowing capacity (the “Additional Loan” and, together with the original Loan, the “Loan”) under the existing $1 million secured revolving line of credit established under the Original Loan Agreement. The Company may draw on the line to fund working capital. The Additional Loan, which is represented by a Promissory Note dated October 11, 2013 (the “New Note”), matures on June 20, 2014. On October 11, 2013, $280,750 was drawn on the Additional Loan, $30,750 of which was retained by Platinum to cover applicable fees.
The Company plans to utilize funds drawn on the Additional Loan to fund its ongoing operations. Borrowings accrue interest at the rate of 18% per annum, payable monthly on or before the last calendar day of each month, and a service charge of 3% applies to late payments. An interest reserve of $133,500 has been set aside from the proceeds of the New Note to make required payments of interest, provided that interest billed to the Company will first be deducted from a $90,000 reserve established under the Original Note for payments of interest on the Original Note, until that reserve has been exhausted. The Amended Loan Agreement also provides for payment of an accommodation fee of $25,000 and a closing fee of $3,250, the amounts of which were retained by Platinum out of amounts drawn on the Additional Loan on October 11, 2013. The Company’s obligations under the Amended Loan Agreement are not guaranteed by any other party. The Company may prepay borrowings without premium or penalty upon notice to Platinum as provided in the Amended Loan Agreement. The Loan is secured by a security agreement, under which the Company grants Platinum first priority security interest in the Company’s inventory, equipment, accounts and other rights to payments and intangibles as security for the Loan. The New Note provides for monthly interest payments commencing November 2013 and for repayment of all amounts drawn, together with accrued interest, on June 20, 2014.
On October 15, 2013, plaintiff Mark P. Sennott, as Trustee of the Sennott Family Charitable Trust, (“Plaintiff”) filed a complaint derivatively, on behalf of Apollo Diamond, Inc. (“Apollo”), in the U.S. District Court for the District of South Carolina, Greenville Division, against Edward S. Adams (our Chairman), Michael R. Monahan (a former member of the Company’s Board of Directors), the law firm of Adams Monahan, LLP, Loblolly, Inc., which was formerly known as Scio Diamond Technology Corporation, and the Company (collectively, “Defendants”). This derivative complaint on Apollo’s behalf (the “Apollo Derivative Complaint”) alleges claims for breach of fiduciary duty, constructive fraud and unjust enrichment. The allegations in the Apollo Derivative complaint are duplicative of the Scio Derivative Complaint allegations concerning Apollo, and repeat almost verbatim the allegations from earlier lawsuits filed and dismissed in 2012 against the Defendants, which were previously disclosed in the Company’s Form 10-Q for the six months ended September 30, 2012 and Form 10-K for fiscal year ended March 31, 2013. Plaintiff is seeking direct and consequential damages sustained by Plaintiff in an amount to be established through proof at trial, plus pre-judgment and post-judgment interest; appropriate equitable relief to remedy the allegedly wrongful acts; reasonable attorney’s fees and costs incurred in prosecuting the action; and other relief as deemed by the court to be just and proper. The Defendants believe the Apollo Derivative Complaint has no merit and are vigorously defending it.
|
Going Concern
The Company has generated very little revenue to date and consequently its operations are subject to all risks inherent in the establishment and commercial launch of a new business enterprise.
These factors raise substantial doubt about the Company’s ability to continue as a going concern. Management has responded to these circumstances by taking the following actions:
· On-going solicitation of investment in the Company in the form of private placements of common shares, secured and unsecured debt to accredited investors;
· Focused efforts on new business development opportunities to generate incremental revenues and diversify our customer base; and
· Began exploring strategic joint ventures, technology licensing agreements and dedicated contract manufacturing to expand company revenue and cash flow including our recently agreed to joint venture in China.
In the opinion of management, these actions should be sufficient to provide the Company with the liquidity it needs to meet its obligations and continue as a going concern. There can be no assurance, however, that the Company will successfully implement these plans. The financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.
Accounting Basis
The accompanying unaudited financial statements of the Company have been prepared in accordance with accounting principles generally accepted in the United States of America (“GAAP”) for interim financial information and with the instructions to Form 10-Q and Rule 10-01 of Regulation S-X. Accordingly, certain information and footnote disclosures normally included in financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations.
In the opinion of management, the accompanying unaudited financial statements contain all adjustments (consisting only of normal recurring accruals) necessary to present fairly the Company’s financial position as of September 30, 2013 and March 31, 2013 and the results of operations and cash flows for the three and six month interim periods ended September 30, 2013 and 2012. All interim amounts have not been audited, and the results of operations for the interim periods herein are not necessarily indicative of the results of operations to be expected for future periods or the year. The balance sheet at March 31, 2013 has been derived from the audited financial statements at that date but does not include all of the information and footnotes required by GAAP for complete financial statements. These financial statements should be read in conjunction with the Company’s audited financial statements and notes thereto included in the Form 10-K Annual Report of the Company for the year ended March 31, 2013.
Basic and Diluted Net Loss per Share
Net loss per share is presented under two formats: basic net loss per common share, which is computed using the weighted
average number of common shares outstanding during the period, and diluted net loss per common share, which is computed using the weighted average number of common shares outstanding, and the weighted average dilutive potential common shares outstanding, computed using the treasury stock method. Currently, for all periods presented, diluted net loss per share is the same as basic net loss per share as the inclusion of weighted average shares of common stock issuable upon the exercise of options and warrants would be anti-dilutive.
The following table summarizes the number of securities outstanding at each of the periods presented, which were not included in the calculation of diluted net loss per share as their inclusion would be anti-dilutive:
|
|
September 30, |
| ||
|
|
2013 |
|
2012 |
|
Common stock options and warrants |
|
9,778,045 |
|
10,791,264 |
|
Allowance for Doubtful Accounts
An allowance for uncollectible accounts receivable is maintained for estimated losses from customers’ failure to make payment on accounts receivable due to the Company. Management determines the estimate of the allowance for uncollectible accounts receivable by considering a number of factors, including: (1) historical experience, (2) aging of accounts receivable and (3) specific information obtained by the Company on the financial condition and the current credit worthiness of its customers. The Company has determined that an allowance was not necessary at September 30, 2013 or March 31, 2013.
Inventories
Inventories are stated at the lower of average cost or market. The carrying value of inventory is reviewed and adjusted based upon slow moving and obsolete items. Inventory costs include material, labor, and manufacturing overhead and are determined by the “first-in, first-out” (“FIFO”) method. The components of inventories are as follows:
|
|
September 30, |
|
March 31, |
| ||
Raw materials and supplies |
|
$ |
132,462 |
|
$ |
64,255 |
|
Work in process |
|
22,486 |
|
— |
| ||
Finished goods |
|
331,911 |
|
474,693 |
| ||
|
|
486,859 |
|
538,948 |
| ||
Inventory reserves |
|
(55,508 |
) |
— |
| ||
|
|
$ |
431,351 |
|
$ |
538,948 |
|
During the six months ended September 30, 2013, we established a lower cost of market reserve of $55,508 due to expected selling prices being lower than cost. The estimation of the total write-down involves management judgments and assumptions including assumptions regarding future selling price forecasts, the estimated costs to complete, disposal costs and an expected profit margin.
Property, Plant and Equipment
Depreciation of property, plant and equipment is on a straight line basis beginning at the time it is placed in service, based on the following estimated useful lives:
|
|
Years |
|
Machinery and equipment |
|
3–15 |
|
Furniture and fixtures |
|
3–10 |
|
Engineering equipment |
|
5–12 |
|
Leasehold improvements are depreciated over the lesser of the remaining term of the lease or the life of the asset (generally three to seven years).
Expenditures for major renewals and betterments that extend the useful lives of property and equipment are capitalized. Expenditures for maintenance and repairs are charged to expense as incurred. Manufacturing equipment was placed into service beginning July 1, 2012.
Intangible Assets
Intangible assets, such as acquired in-process research and development costs, are considered to have an indefinite useful life until such time as they are put into service at which time they will be amortized on a straight-line basis over the shorter of their economic or legal useful life. Management evaluates indefinite life intangible assets for impairment on an annual basis and on an interim basis if events or changes in circumstances between annual impairment tests indicate that the asset might be impaired. The ongoing evaluation for impairment of its indefinite life intangible assets requires significant management estimates and judgment.
Management reviews definite life intangible assets for impairment whenever events or changes in circumstances indicate that the carrying amount of an asset may not be recoverable. There were no impairment charges during the six months ended September 30, 2013 or 2012.
Fair Value Measurement
Fair value is defined as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. The fair value hierarchy prescribed by the accounting literature contains three levels as follows:
Level 1— Quoted prices in active markets for identical assets or liabilities.
Level 2— Observable inputs other than Level 1 prices such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
Level 3— Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. Level 3 assets and liabilities include financial instruments whose value is determined using pricing models, discounted cash flow methodologies, or similar techniques, as well as instruments for which the determination of fair value requires significant management judgment or estimation.
In addition, GAAP requires the Company to disclose the fair value for financial assets on both a recurring and non-recurring basis. On August 31, 2011, the Company issued to certain current and former stockholders of Apollo Diamond Inc. (“ADI”) that were at that time accredited investors subscription rights valued at $11,040,000 for the purchase of ADI assets disclosed in Note 2 measured at fair value on a nonrecurring basis. The fair value of the ADI subscription rights was determined based on an appraisal which used the Black-Scholes model whose assumptions were considered by management to be a Level 3 input. During September 2012, the Company issued to certain current and former stockholders of Apollo Diamond Gemstone Corporation (“ADGC”) that were at the time accredited investors subscription rights valued at $770,000 for the purchase of ADGC assets disclosed in Note 2 measured at fair value on a nonrecurring basis. The fair value of the ADGC subscription rights was determined using the Black-Scholes model whose assumptions were considered by management to be a Level 3 input.
As of September 30, 2013, the Company had 425,545 warrants outstanding with exercise prices of $0.70 per share. The warrants expire in 2016 and 2017. The warrants were issued by the Company as compensation for consulting work, placement agent services, and in exchange for cash discounts on facility rent, and are valued at $0.52 per warrant using the Black-Scholes model. In addition, the Company has 200,000 warrants outstanding with exercise prices of $1.60 per share. These warrants expire in 2018 and were issued by the Company as compensation to a Board member and an unaffiliated third party for efforts related to the Company’s largest customer and were valued at $0.57 per warrant using the Black-Scholes model.
The carrying value of cash and cash equivalents including restricted cash, accounts receivable, other assets and trade accounts payable approximates fair value due to the short-term nature of these instruments.
Revenue Recognition
We recognize revenue when persuasive evidence of an arrangement exists, delivery of products has occurred, the sales price is fixed or determinable, and collectability is reasonably assured. For our Company, this generally means that we recognize revenue when we or our fabrication vendor has shipped finished product to the customer. Our sales terms do not allow for a right of return except for matters related to any manufacturing defects on our part. The Company also maintains a provision for estimating returns and allowances based upon historical experience.
Recent Accounting Pronouncements
There are currently no accounting standards that have been issued but not yet adopted by the Company that will have a significant impact on the Company’s financial position, results of operations or cash flows upon adoption.
|
|
|
September 30, |
| ||
|
|
2013 |
|
2012 |
|
Common stock options and warrants |
|
9,778,045 |
|
10,791,264 |
|
|
|
September 30, |
|
March 31, |
| ||
Raw materials and supplies |
|
$ |
132,462 |
|
$ |
64,255 |
|
Work in process |
|
22,486 |
|
— |
| ||
Finished goods |
|
331,911 |
|
474,693 |
| ||
|
|
486,859 |
|
538,948 |
| ||
Inventory reserves |
|
(55,508 |
) |
— |
| ||
|
|
$ |
431,351 |
|
$ |
538,948 |
|
|
|
Years |
|
Machinery and equipment |
|
3–15 |
|
Furniture and fixtures |
|
3–10 |
|
Engineering equipment |
|
5–12 |
|
|
Inventory |
|
$ |
269,000 |
|
In-process research and development |
|
601,000 |
| |
Total |
|
$ |
870,000 |
|
|
|
|
|
|
September 30, |
|
March 31, |
| ||
|
|
Life |
|
2013 |
|
2013 |
| ||
Patents, gross |
|
6.75 – 19.46 |
|
$ |
8,135,063 |
|
$ |
7,534,063 |
|
In-process research and development |
|
Indefinite |
|
2,250,435 |
|
2,851,435 |
| ||
|
|
|
|
10,385,498 |
|
10,385,498 |
| ||
Accumulated amortization |
|
|
|
757,353 |
|
369,847 |
| ||
Net intangible assets |
|
|
|
$ |
9,628,145 |
|
$ |
10,015,651 |
|
Fiscal Year Ending |
|
|
| |
Six months ending March 31, 2014 |
|
$ |
387,506 |
|
March 31, 2015 |
|
775,011 |
| |
March 31, 2016 |
|
775,011 |
| |
March 31, 2017 |
|
775,011 |
| |
March 31, 2018 |
|
775,011 |
| |
Thereafter |
|
$ |
3,890,160 |
|
|
Expected dividend yield |
|
0.00 |
% | |
Risk-free interest rate |
|
.66 |
% | |
Expected life in years |
|
3.00 |
| |
Expected volatility |
|
102.3 |
% | |
Weighted average calculated value of options granted |
|
$ |
0.21 |
|
Options |
|
Shares |
|
Weighted- |
|
Weighted-Average |
| |
Options Outstanding March 31, 2013 |
|
4,092,500 |
|
$ |
0.87 |
|
2.54 |
|
Granted |
|
500,000 |
|
0.33 |
|
2.99 |
| |
Exercised |
|
— |
|
— |
|
— |
| |
Expired/cancelled |
|
(406,250 |
) |
0.88 |
|
— |
| |
Options Outstanding September 30, 2013 |
|
4,186,250 |
|
$ |
0.79 |
|
1.87 |
|
Exercisable at September 30, 2013 |
|
1,703,833 |
|
$ |
0.82 |
|
2.01 |
|
|
|
|
|
Weighted Average |
| |
|
|
|
|
Grant-Date |
| |
Non-vested Shares |
|
Shares |
|
Fair Value |
| |
Non-vested at March 31, 2013 |
|
2,466,278 |
|
$ |
0.65 |
|
Granted |
|
500,000 |
|
0.21 |
| |
Vested |
|
(343,750 |
) |
0.73 |
| |
Expired/cancelled: non-vested |
|
(200,000 |
) |
0.43 |
| |
Non-vested at September 30, 2013 |
|
2,482,417 |
|
$ |
0.57 |
|
|
|
|
|
|
|
|
|
|
|
|
|